Statistics from Altmetric.com
“When will I be able to play again?” is usually the reflex thought when an athlete suffers an injury. When making return to play decisions, clinicians (including physiotherapists, athletic trainers and physicians) and athletes might engage in a risk–benefit analysis of sorts, consciously or unconsciously weighing up the risks associated with participation and the extent to which those risks can be tolerated.1 ,2 There are a number of questions to contemplate: How does the clinician determine when the athlete is ready to return to play? Is physical recovery alone enough for return to play? What is successful return to play? What are the sports medicine clinician's responsibilities within the team, and to the athlete? Should athletes even return to play?
But what evidence can be used to answer these questions? We highlight some of the complexities in making the return to play decision, and key areas that need to be addressed.
How does the clinician determine when the athlete is ready to return to play?
In the traditional evidence-based practice model,3 the clinician integrates the best available evidence from research with individual clinical experience and the patient's preferences when making decisions. In the search for the best evidence, considering an ankle sprain, the clinician might consult a textbook, where the evidence says that the athlete should have no pain or swelling, full strength and range of motion, and a healed ligament before returning to full competition.4 The time taken for pain and swelling to subside and full range of motion to return might vary from a couple of weeks to a couple of months; it may take a year for ligament healing.5 But in real life the athlete may return to play within 1 or 2 weeks of …
Correction notice This paper has been significantly amended since it was published Online First. New reference 2 has been inserted. Figure 1 has been updated and the captions for figures 1 and 2 have been changed. Reference 1 has also been updated to use the StAARt reference.
Twitter Follow Clare Ardern at @clare_ardern
Contributors CLA wrote the first draft and is the guarantor. All authors contributed to the conception of this editorial; revised the manuscript for important intellectual content and approved the final version.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.